A phone call after the ER: testing a suicide prevention lifeline

NCT ID NCT05307432

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial tests whether a safety planning intervention plus follow-up phone calls, delivered either by emergency department staff or via a telehealth referral center, can reduce suicide attempts and deaths in adults who come to the ER with suicidal thoughts or behaviors. Over 2,800 participants across multiple sites will be followed to see if the program improves engagement with mental health care and lowers suicide-related events. The goal is to find a practical, scalable way to support people at risk after they leave the hospital.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Safety Planning Intervention plus follow-up phone calls (SPI+) delivered by ED staff or via telehealth referral
What this could lead to
If effective, this approach could provide a scalable, telehealth-based suicide prevention strategy that reaches more at-risk patients after they leave the emergency department.
What could go wrong
The trial is large but relies on real-world implementation, so results may vary across sites. The intervention may not reduce suicide attempts or deaths if follow-up engagement is low.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergencies Suicidal Ideation Suicide

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Pennsylvania Health System

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.